Literature DB >> 26022882

Food allergy: psychosocial impact and public policy implications.

Hemant P Sharma1, Linda J Herbert.   

Abstract

Given its increasing prevalence and potential severity, food allergy not only negatively impacts the health and quality of life of affected individuals but also carries a significant economic burden. To address these problems, a community approach including efforts to increase awareness of food allergy among the general public and the implementation of appropriate public policies to keep affected individuals safe is required. This chapter reviews the general public's knowledge and perceptions of food allergy, the disease's psychosocial impact on affected individuals, and the current state and future directions of food allergy public policy.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26022882     DOI: 10.1159/000373907

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN: 0079-6034


  4 in total

1.  Anti-Allergic Compounds from the Deep-Sea-Derived Actinomycete Nesterenkonia flava MCCC 1K00610.

Authors:  Chun-Lan Xie; Qingmei Liu; Jin-Mei Xia; Yuanyuan Gao; Quan Yang; Zong-Ze Shao; Guangming Liu; Xian-Wen Yang
Journal:  Mar Drugs       Date:  2017-03-14       Impact factor: 5.118

2.  IgE binds asymmetrically to its B cell receptor CD23.

Authors:  Balvinder Dhaliwal; Marie O Y Pang; Anthony H Keeble; Louisa K James; Hannah J Gould; James M McDonnell; Brian J Sutton; Andrew J Beavil
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

3.  Single-dose AAV vector gene immunotherapy to treat food allergy.

Authors:  Miguel Gonzalez-Visiedo; Xin Li; Maite Munoz-Melero; Michael D Kulis; Henry Daniell; David M Markusic
Journal:  Mol Ther Methods Clin Dev       Date:  2022-07-16       Impact factor: 5.849

Review 4.  CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy.

Authors:  P Bégin; E S Chan; H Kim; M Wagner; M S Cellier; C Favron-Godbout; E M Abrams; M Ben-Shoshan; S B Cameron; S Carr; D Fischer; A Haynes; S Kapur; M N Primeau; J Upton; T K Vander Leek; M M Goetghebeur
Journal:  Allergy Asthma Clin Immunol       Date:  2020-03-18       Impact factor: 3.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.